PeptiDream
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates.
Launch date
Employees
Market cap
AUD3.8b
Enterprise valuation
AUD3.8b (Public information from Sep 2024)
Share price
JPY2447.5 4587.T
Tokyo Japan (HQ)
Financials
Estimates*
JPY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 11.7b | 9.4b | 26.9b | 28.7b | 46.0b | 40.3b | 44.3b |
% growth | - | (20 %) | 187 % | 7 % | 60 % | (12 %) | 10 % |
EBITDA | 8.5b | 5.0b | 10.9b | 9.0b | 24.3b | 16.6b | 18.1b |
% EBITDA margin | 73 % | 53 % | 41 % | 31 % | 53 % | 41 % | 41 % |
Profit | 4.4b | 3.6b | 7.6b | 3.0b | 16.2b | 10.7b | 12.4b |
% profit margin | 38 % | 39 % | 28 % | 11 % | 35 % | 26 % | 28 % |
EV / revenue | 55.8x | 34.0x | 10.2x | 6.8x | 6.8x | 7.5x | 6.6x |
EV / EBITDA | 76.5x | 63.7x | 25.1x | 21.6x | 12.9x | 18.2x | 16.2x |
R&D budget | - | 1.7b | 2.9b | 3.2b | - | - | - |
R&D % of revenue | - | 18 % | 11 % | 11 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Early VC | |
JPY299m | Late VC | ||
N/A | N/A | IPO | |
Total Funding | AUD3.6m |